JPMorgan Chase & Co’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | -$13 | – | 6560 |
|
|
2024
Q4 | $13 | Sell |
3
-2
| -40% | -$9 | ﹤0.01% | 6249 |
|
|
2024
Q3 | $43 | Hold |
5
| – | – | ﹤0.01% | 6073 |
|
|
2024
Q2 | $43 | Sell |
5
-1
| -17% | -$9 | ﹤0.01% | 6027 |
|
|
2024
Q1 | $112 | Sell |
6
-2
| -25% | -$37 | ﹤0.01% | 5872 |
|
|
2023
Q4 | $212 | Hold |
8
| – | – | ﹤0.01% | 6004 |
|
|
2023
Q3 | $391 | Hold |
8
| – | – | ﹤0.01% | 5798 |
|
|
2023
Q2 | $351 | Buy |
+8
| New | +$351 | ﹤0.01% | 5668 |
|
|
2022
Q1 | – | Sell |
-200
| Closed | -$107K | – | 5896 |
|
|
2021
Q4 | $107K | Buy |
+200
| New | +$107K | ﹤0.01% | 4795 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5691 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5616 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5350 |
|
|
2020
Q4 | – | Sell |
-11
| Closed | -$27K | – | 5051 |
|
|
2020
Q3 | $27K | Buy |
+11
| New | +$27K | ﹤0.01% | 4440 |
|
|
2019
Q4 | – | Sell |
-2
| Closed | -$7K | – | 4846 |
|
|
2019
Q3 | $7K | Buy |
+2
| New | +$7K | ﹤0.01% | 4608 |
|